Heart failure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

Kidney Int. 2019 Jun;95(6):1304-1317. doi: 10.1016/j.kint.2019.02.022. Epub 2019 Apr 30.

Abstract

The incidence and prevalence of heart failure (HF) and chronic kidney disease (CKD) are increasing, and as such a better understanding of the interface between both conditions is imperative for developing optimal strategies for their detection, prevention, diagnosis, and management. To this end, Kidney Disease: Improving Global Outcomes (KDIGO) convened an international, multidisciplinary Controversies Conference titled Heart Failure in CKD. Breakout group discussions included (i) HF with preserved ejection fraction (HFpEF) and nondialysis CKD, (ii) HF with reduced ejection fraction (HFrEF) and nondialysis CKD, (iii) HFpEF and dialysis-dependent CKD, (iv) HFrEF and dialysis-dependent CKD, and (v) HF in kidney transplant patients. The questions that formed the basis of discussions are available on the KDIGO website http://kdigo.org/conferences/heart-failure-in-ckd/, and the deliberations from the conference are summarized here.

Keywords: cardiovascular disease; chronic kidney disease; congestive heart failure; hemodialysis; transplantation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Congresses as Topic
  • Glomerular Filtration Rate / physiology
  • Heart Failure / diagnosis
  • Heart Failure / epidemiology*
  • Heart Failure / etiology
  • Heart Failure / prevention & control
  • Humans
  • Incidence
  • Kidney Transplantation*
  • Prevalence
  • Renal Dialysis*
  • Renal Elimination / physiology
  • Renal Insufficiency, Chronic / blood
  • Renal Insufficiency, Chronic / complications*
  • Renal Insufficiency, Chronic / diagnosis
  • Renal Insufficiency, Chronic / therapy
  • Risk Factors
  • Stroke Volume / physiology
  • Urea / blood
  • Urea / metabolism

Substances

  • Urea